We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Advertising (257)
- Legislation (84)
- COVID-19 (66)
- Compliance and enforcement (51)
- Vaping hub (46)
- Manufacturing (29)
- Import and export (22)
- Labelling and packaging (20)
- Medicinal cannabis hub (20)
- Scheduling (national classification system) (19)
- Safety monitoring and information (13)
- Weight loss products (6)
- Shortages and supply disruptions (4)
- Cosmetics (3)
- Committees and advisory bodies (2)
- Prescription opioids hub (2)
- Sunscreens (2)
- Unique Device Identification (UDI) hub (2)
- Clinical trials (1)
- Fees and payments (1)
- Urogynaecological (transvaginal) surgical mesh hub (1)
Search
712 result(s) found, displaying 126 to 150
-
Media releasesTGA has accepted a court enforceable undertaking from Yossef Wahib, operator of the online store Aussie Mega Supplements. Mr Wahib was also issued an infringement notice for $3,756.
-
Media releasesIf your business is involved with medicinal cannabis, read our updated guidance about advertising medicinal cannabis to consumers.
-
Media releasesWe have issued infringement notices for $13,656 to 2 registered nurses for allegedly importing unapproved cosmetic injectables and advertising prescription-only medicines.
-
Media releasesFrom 1 January 2024, the importation of disposable vapes will be prohibited, subject to very limited exceptions. Read more about the first stage of Australia’s vaping reforms.
-
Regulatory decision noticesWe have issued a notice to Pracmed Healthcare Pty Ltd to cease advertising indications related to weight loss surgery and cognitive function.
-
Regulatory decision noticesWe've created a new GMP clearance Sponsor Information Dashboard (SID) to provide industry with current information about our processing times, workload and key messages. We have also updated our GMP clearance guidance.
-
Regulatory decision noticesFind out about how GMP clearances for manufacturing sites in Bulgaria can now be assessed via the Mutual Recognition Agreement (MRA) pathway.
-
Regulatory decision noticesInformation about GMP clearances issued via the MRA Pathway that expire on 31 December 2023 as well as information on the ongoing use of the GMP clearance questionnaire.
-
Media releasesIf you use a Philips Continuous Positive Airway Pressure (CPAP) machine or a Bi-level Positive Airway Pressure (Bi-Level PAP) machine you may be affected by this recall action. Register your machine for repair or replacement to avoid any potential risks.
-
Media releasesWe have alleged that the advertising on the company's website and social media was unlawful because medicinal cannabis products are prescription-only medicines that can't be advertised directly to consumers.
-
Media releasesThe changes will help address the significant public health issues caused by vaping in Australia, while keeping legitimate patient access to therapeutic vapes.
-
Media releasesWe've worked with the Australian Border Force to keep more than 307,000 units of unlawfully imported medicines and medical devices out of the Australian market.
-
Media releasesWe have issued 45 infringement notices totalling $742,500 to InstantScripts Pty Ltd for the alleged unlawful advertising of prescription-only medicines.
-
Regulatory decision noticesWe've granted a labelling exemption for the COVID-19 Vaccine, Pfizer (raxtozinameran), under the current Poisons Standard.
-
Media releasesThe Federal Court of Australia has ordered Vapor Kings Pty Ltd to pay $4.9 million for unlawfully advertising nicotine vaping products. A company Director was also ordered to pay $100,000 in penalties.
-
Media releasesWe have issued infringement notices totalling $82,632 to Ovira Pty Ltd, and an individual, for the alleged unlawful advertising of an analgesic TENS system.
-
Regulatory decision noticesFind out how listed medicine ingredients, and requirements for their use, have been updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 4) 2023.
-
Media releasesWe have executed warrants on storage units in Sydney and seized more than 70,000 vaping products, with an estimated street value of over $2.1 million. They will be tested for dangerous and undeclared chemicals at our labs.
-
Regulatory decision noticesArrangement under subsection 7C(1) of the Therapeutic Goods Act 1989
-
Media releasesWe have issued infringement notices to the company Naturally Elevated Pty Ltd and an individual for the alleged unlawful advertising of medicinal cannabis on websites and social media pages.
-
Regulatory decision noticesThis instrument is made under subregulation 10JD(4) of the Therapeutic Goods Regulations 1990.
-
Media releasesOn 29 August 2023, the TGA executed multiple warrants on storage units and residences in Brisbane and seized over 40,000 vaping products with an estimated street value of over $1.2 million
-
Media releasesWe have issued infringement notices for $26,640 to Nius Development Pty Ltd for the alleged unlawful import of unapproved cosmetic injectable products.
-
Media releasesThe TGA has issued 7 infringement notices totalling $115,500 to the company for the alleged unlawful advertising and supply of sport supplement products containing banned substances.
-
Media releasesThe TGA has issued five infringement notices totalling $82,500 were issued to the company, and 3 notices totalling $9,900 were issued to an individual.